Dr Dy Patil Institute Of Biotechnology And Bioinformatics

Pune, India

Dr Dy Patil Institute Of Biotechnology And Bioinformatics

Pune, India

Time filter

Source Type

Manisha P.,Institute of Pharmaceutical Education and Research | Bastikar V.A.,Dr Dy Patil Institute Of Biotechnology And Bioinformatics | Animeshchandra H.,Rashtrasant Tukadoji Maharaj Nagpur University | Ingle V.N.,Rashtrasant Tukadoji Maharaj Nagpur University | Wazalwar S.S.,Research and Technology
Bioorganic and Medicinal Chemistry Letters | Year: 2010

A series of 3-chloro-4-substituted-1-(8-hydroxy-quinolin-5-yl)-azetidin-2- ones were synthesized and evaluated for their in vitro anti-filarial activity. To pre-assess the anti-filarial behavior of synthesized compounds (V a-f) on a structural basis, automated docking studies were carried out with Molecular Design Suite (MDS v 3.5) into the active site of glutathione-S-transferase (GST) enzyme; scoring functions of these compounds at the active site of the GST enzyme were used for correlation with observed activity. Compounds V e and V f have shown good affinity for receptor GST, as well as in vitro anti-filarial potency. © 2010 Elsevier Ltd.


Hiwanj P.B.,Dr Dy Patil Institute Of Biotechnology And Bioinformatics | Bastikar V.A.,Dr Dy Patil Institute Of Biotechnology And Bioinformatics | Mahajan N.P.,Pain and Inflammation Laboratory Jubilant Biosys Ltd
International Journal of ChemTech Research | Year: 2010

In the present investigation novel substituted benzimidazoles are designed and docked in to active site of Cyclooxygenase II. Ligands are designed based on the structure of receptor, COX-II and well known NSAID Celecoxib. Further In- Silico docking analysis of designed ligands are performed to predict binding mode, orientations and affinity. Ligands number 38, 39, 40, 41, 42, 43 and 44 are having less binding energy in kj/mole and said to possess more affinity for receptor than other molecules and celecoxib.


Shingnapurkar D.,University of Pune | Dandawate P.,University of Pune | Anson C.E.,Karlsruhe Institute of Technology | Powell A.K.,Karlsruhe Institute of Technology | And 6 more authors.
Bioorganic and Medicinal Chemistry Letters | Year: 2012

Currently used anti-tubercular drugs target actively growing Mycobacterium tuberculosis (Mtb) but there are no current therapies targeting persistent mycobacteria. Isocitrate lyase (ICL) is an important enzyme of the glyoxylate shunt pathway used by Mtb for sustaining intracellular infection in inflammatory macrophages under conditions of stress such as nutrient depletion and anaerobic metabolism. Since the humans do not possess this enzyme it constitutes an attractive target for selective drug design. Present work describes synthesis and structural characterization of pyruvate-isoniazid conjugates and their copper complexes with potent anti-tubercular activities against M. tuberculosis H37Rv. © 2012 Elsevier Ltd. All rights reserved.

Loading Dr Dy Patil Institute Of Biotechnology And Bioinformatics collaborators
Loading Dr Dy Patil Institute Of Biotechnology And Bioinformatics collaborators